RAFAEL HOLDINGS, INC. Shareholders' Equity
RAFAEL HOLDINGS, INC. (RFL) had Shareholders' Equity of $75.39 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-06-11
- 2026-04-30: Stockholders' Equity Attributable to Parent $75.39M.
- 2026-01-31: Stockholders' Equity Attributable to Parent $79.17M.
- 2025-10-31: Stockholders' Equity Attributable to Parent $85.18M.
- 2025-07-31: Stockholders' Equity Attributable to Parent $94.39M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-04-30 | $75.39M 10-Q · filed 2026-06-11 | |
| 2026-01-31 | $79.17M 10-Q · filed 2026-03-16 | |
| 2025-10-31 | $85.18M 10-Q · filed 2025-12-12 | |
| 2025-07-31 | $94.39M 10-Q · filed 2026-06-11 | |
| 2025-04-30 | $80.58M 10-Q · filed 2025-06-11 | |
| 2025-01-31 | $69.38M 10-Q · filed 2025-03-14 | |
| 2024-10-31 | $73.52M 10-Q · filed 2024-12-11 | |
| 2024-07-31 | $82.19M 10-K · filed 2025-10-29 | |
| 2024-04-30 | $86.10M 10-Q · filed 2024-06-14 | |
| 2024-01-31 | $104.94M 10-Q · filed 2024-03-14 | |
| 2023-10-31 | $98.20M 10-Q · filed 2023-12-14 | |
| 2023-07-31 | $100.29M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $98.53M 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $100.10M 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $103.37M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $100.52M 10-K · filed 2023-10-30 | |
| 2022-04-30 | $98.15M 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $102.88M 10-Q · filed 2022-03-17 | |
| 2021-10-31 | $116.03M 10-Q/A · filed 2022-02-28 | $98.74M 10-Q · filed 2021-12-15 |
| 2021-07-31 | $122.29M 10-K · filed 2022-10-31 | |
| 2021-04-30 | $126.77M 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $120.80M 10-Q · filed 2021-03-17 | |
| 2020-10-31 | $115.57M 10-Q · filed 2020-12-15 | |
| 2020-07-31 | $116.80M 10-K · filed 2021-10-18 | |
| 2020-04-30 | $122.06M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $124.06M 10-Q · filed 2020-03-05 | |
| 2019-10-31 | $125.15M 10-Q · filed 2019-12-09 | |
| 2019-07-31 | $110.98M 10-K · filed 2020-10-29 | |
| 2019-04-30 | $118.00M 10-Q · filed 2019-06-05 | |
| 2019-01-31 | $118.83M 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $106.44M 10-Q · filed 2018-12-10 | |
| 2018-07-31 | $106.70M 10-K · filed 2019-10-04 | |
| 2018-04-30 | $105.44M 10-Q · filed 2018-06-11 | |
| 2018-01-31 | $42.95M 10-Q · filed 2018-03-12 | |
| 2017-07-31 | $52.74M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |